These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1965656)

  • 21. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre- and postsynaptic adrenergic dysfunctions in hypertension.
    de Champlain J
    J Hypertens Suppl; 1990 Dec; 8(7):S77-85. PubMed ID: 1965658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation.
    Rundqvist B; Elam M; Eisenhofer G; Friberg P
    J Heart Lung Transplant; 1996 May; 15(5):516-26. PubMed ID: 8771507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of variability in arterial blood pressure at rest using spectral analysis in hypertensive patients.
    Siché JP; Tremel F; Comparat V; de Gaudemaris R; Mallion JM
    J Hypertens; 1995 Jan; 13(1):147-53. PubMed ID: 7759845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure.
    Mark AL
    J Hypertens Suppl; 1996 Dec; 14(5):S159-65. PubMed ID: 9120673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of the sympathetic nervous system to hypertension in diabetes mellitus.
    Kribben A; Philipp T
    Diabete Metab; 1989; 15(5 Pt 2):313-7. PubMed ID: 2693150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurogenic factors in hypertension: therapeutic implications.
    Campese VM
    Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation?
    Hausberg M; Grassi G
    J Hypertens; 2007 Jan; 25(1):47-9. PubMed ID: 17143171
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension.
    Rubino A; Burnstock G
    J Pharmacol Exp Ther; 1995 Oct; 275(1):422-8. PubMed ID: 7562580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic overactivity in uremia.
    Ksiazek A; Załuska W
    J Ren Nutr; 2008 Jan; 18(1):118-21. PubMed ID: 18089457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathetic activation in chronic renal failure.
    Schlaich MP; Socratous F; Hennebry S; Eikelis N; Lambert EA; Straznicky N; Esler MD; Lambert GW
    J Am Soc Nephrol; 2009 May; 20(5):933-9. PubMed ID: 18799718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional norepinephrine turnover in human hypertension.
    Esler M; Lambert G; Jennings G
    Clin Exp Hypertens A; 1989; 11 Suppl 1():75-89. PubMed ID: 2743607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Essential arterial hypertension. 1. Epidemiology. Pathogenesis. In practice...one should remember...].
    Ménard J
    Rev Prat; 1979 Dec; 29(55):4285-6, 4289. PubMed ID: 531456
    [No Abstract]   [Full Text] [Related]  

  • 37. Behaviour of the adrenergic cardiovascular drive in atrial fibrillation and cardiac arrhythmias.
    Grassi G; Seravalle G; Bertinieri G; Mancia G
    Acta Physiol Scand; 2003 Mar; 177(3):399-404. PubMed ID: 12609012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stress, the sympathetic nervous system and hypertension.
    Kaplan NM
    J Human Stress; 1978 Sep; 4(3):29-34. PubMed ID: 690419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathetic overactivity and arterial hypertension in renal failure.
    Orth SR; Amann K; Strojek K; Ritz E
    Nephrol Dial Transplant; 2001; 16 Suppl 1():67-9. PubMed ID: 11369825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the sympathetic nervous system in human hypertension.
    Grassi G
    J Hypertens; 1998 Dec; 16(12 Pt 2):1979-87. PubMed ID: 9886886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.